Skip to main content

Want a detailed portfolio tracker?

Caribou Biosciences (CRBU) P/E (2021 - 2026)

Caribou Biosciences (CRBU) P/E from Jul 23, 2021 to Jul 21, 2026. The TTM Caribou Biosciences (CRBU) P/E is -1.17. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Caribou Biosciences (CRBU)

YearP/EChange
2026-1.17+16.36%
2025-1.00+3.58%
2024-0.97-75.32%
2023-3.93-6.39%
2022-4.19-58.41%
2021-10.09N/A

Comparison Caribou Biosciences (CRBU) P/E with competitors

Caribou Biosciences (CRBU) P/E is -1.17.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.15%
NBYStablecoin Development Corp0.00-100.37%
ENLVEnlivex Ltd0.07-106.40%
FGENFibroGen Inc0.24-120.55%
CHRSCoherus Biosciences Inc0.85-172.65%
FBIOFortress Biotech Inc0.95-181.26%
ORMPOramed Pharmaceuticals Inc1.50-228.69%
AGENAgenus Inc3.01-357.69%
INVAInnoviva Inc3.15-370.05%
VXRTVaxart Inc3.55-403.93%
CVACCureVac N.V.4.45-480.65%
GLPGGalapagos NV4.86-516.03%
SRPTSarepta Therapeutics Inc4.88-518.01%
ABEOAbeona Therapeutics Inc5.39-561.29%
ABUSArbutus Biopharma Corp5.60-579.11%
ZVRAZevra Therapeutics Inc5.89-604.07%
SPROSpero Therapeutics Inc6.23-633.29%
CGENCompugen Ltd6.31-640.61%
RIGLRigel Pharmaceuticals6.87-688.40%
SLXNSilexion Therapeutics Corp7.30-724.70%
OMEROmeros Corporation9.26-892.75%
AUPHAurinia Pharmaceuticals Inc9.58-920.68%
PLXProtalix BioTherapeutics Inc10.89-1032.51%
ACADAcadia Pharmaceuticals Inc11.73-1104.22%
TBPHTheravance Biopharma Inc12.26-1149.91%
ADMAAdma Biologics Inc12.42-1163.26%
HRMYHarmony Biosciences Holdings Inc13.82-1283.31%
SABSSAB Biotherapeutics Inc14.14-1310.37%
NAGENiagen Bioscience Inc14.82-1368.76%
INCYIncyte Corp15.82-1454.76%
REGNRegeneron Pharmaceuticals Inc15.86-1457.68%
PBYIPuma Biotechnology Inc17.32-1582.60%
CPRXCatalyst Pharmaceuticals Inc17.44-1593.19%
EXELExelixis Inc17.54-1601.64%
TGTXTG Therapeutics Inc18.97-1723.91%
MDXGMimedx Group Inc20.55-1859.75%
XOMAXOMA Royalty Corp22.87-2058.63%
ARGXArgen X SE24.30-2180.50%
CTMXCytomX Therapeutics Inc24.82-2225.29%
XOMAOXOMA Royalty Corp25.34-2270.13%
HALOHalozyme Therapeutics Inc25.62-2294.01%
XOMAPXOMA Royalty Corp25.67-2297.98%
VRTXVertex Pharmaceuticals Inc27.99-2497.03%
RPRXRoyalty Pharma plc - Class A28.69-2556.35%
SLNOSoleno Therapeutics Inc29.02-2584.42%
ASNDAscendis Pharma A/S30.09-2676.05%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3346.19%
APLSApellis Pharmaceuticals Inc39.02-3441.16%
BMRNBiomarin Pharmaceutical Inc42.21-3714.36%
KRYSKrystal Biotech Inc45.34-3982.50%
ONCBeiGene Ltd69.54-6054.35%
PHARPharming Group N.V.75.03-6524.01%
TECHBio-Techne Corp101.96-8830.11%
VCELVericel Corp109.92-9511.94%
ALNYAlnylam Pharmaceuticals Inc117.96-10200.68%
GMABGenmab140.29-12112.30%
TLXTelix Pharmaceuticals Ltd162.15-13984.22%
CORTCorcept Therapeutics Inc212.86-18325.77%